Functional state of intestinal lamina propria lymphocytes, regulatory mechanisms and their variations during inflammatory bowel disease;Stato funzionale dei linfociti T intestinali, meccanismi di regolazione e loro variazioni nel corso di morbo di Crohn e colite ulcerosa

Annali dell'Istituto Superiore di Sanita

Volumn 35, Issue 2, 1999, Pages 283-287

  Boirivant, Monica ^a   Marini, Marco ^a   Di Felice, Gabriella ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Apoptosis; Cytokine; Inflammatory bowel disease; Mucosal immunity

Indexed keywords

CYTOKINE;

APOPTOSIS; CELLULAR IMMUNITY; CROHN DISEASE; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; INTESTINE MUCOSA; LYMPHOCYTE ACTIVATION; METABOLISM; MUCOSAL IMMUNITY; PHYSIOLOGY; REVIEW; T LYMPHOCYTE SUBPOPULATION; ULCERATIVE COLITIS;

APOPTOSIS; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; IMMUNOPHENOTYPING; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS;

EID: 0042221450     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. KORELITZ, B.I. 1998. Inflammatory bowel disease and pregnancy. Gastroenterol. Clin. North Am. 27: 213-224.
2. CITRIN, O., PARK, Y.H., VEERASUNTHARAM, G., POLACHEK, H., BOLOGA, M., PASTUSZAK, A. & KOREN, G. 1998. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 114: 23-28.
3. KORNFELD, D., CNATTINGIUS, S. & EKBOM, A. 1997. Pregnancy outcomes in women with inflammatory bowel disease, a population-based cohort study. Am. J. Obstet. Gynecol. 177: 942-946.
4. LANGHOLZ, E., MUNKHOLM, P., KRASILMIKOFF, P.A. & BINDER, V. 1997. Inflammatory bowel disease with onset in childhood. Clinical features, morbidity and mortality in a regional cohort. Scand. J. Gastroenterol. 32: 139-147.
5. WALKER-SMITH, J.A. 1997. Therapy of Crohn's disease in childhood. Baillieres Clin. Gastroenterol. 11: 593-610.
6. BRANDTZAEG, P., HALSTESEN, T.S., KETT, K., KRAJCI, P., KVALE, D., ROGNUM, T.O., SCOTT, H. & SOLLID, L.M. 1989. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology 97: 1562-1586.
7. PALLONE, F., FAIS, S., SQUARCIA, O., BIANCONE, L., POZZILLI, P. & BOIRIVANT, M. 1987. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's Disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut 28: 745-775.
8. SCHIEFERDECKER, H.L., ULLRICH, R., HIRSELAND, H. & ZEITZ, M. 1992. T cell differentiation antigens on lymphocytes in the human intestinal lamina propria. J. Immunol. 149: 2816-2822.
9. DE MARIA, R., BOIRIVANT, M., CIFONE, M.G., RONCAIOLI, P., HAHNE, M., TSCHOPP, J., PALLONE, F. & SANTONI, A. 1977. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. J. Clin. Invest. 97: 1-9.
10. PIRZER, U.C., SCHURMANN, G., POST, S., BETZLER, M. & MEUER, S.C. 1990. Differential responsiveness to CD3-Ti vs CD2-dependent activation of human intestinal T lymphocytes. Eur. J. Immunol. 20: 2339-2342.
11. QIAO, L., SCHURMANN, BETZLER, M. & MEUER, S.C. 1991. Activation and signaling status of human lamina propria T lymphocytes. Gastroenterology 101: 1529-1536.
12. TARGAN, S.R., DEEM, R.L., LIU, M., WANG, S. & NEL, A. 1995. Definition of lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway. J. Immunol. 154: 664-675.
13. BOIRIVANT, M., FUSS, I., FIOCCHI, C., KLEIN, J.S., STRONG, S.A. & STROBER, W. 1996. Hypoproliferative human lamina propria T cells retain the capacity to secrete lymphokines when stimulated via CD2/CD28 pathways. Proc. Ass. Am. Physiol. 108: 55-67.
14. KHOO, U.Y., PROCTOR, I.E. & MACPHERSON, A.J.S. 1997. CD4+ cell down-regolation in human intestinal mucosa. J. Immunol. 158: 3626-3634.
15. VAN PARIJIS, L. & ABBAS, AK. 1998. Homeostasis and self-tolerance in the immune-system: turning lymphocytes off. Science 280: 243-248.
16. AKBAR, A.N. & SALMON, M. 1997. Cellular environments and apoptosis: tissue microenvironment control activated T-cell death. Immunol. Today 18: 72-76.
17. SAVILL, J., FADOK, V., HENSON, P. & HASLETT, C. 1993. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14: 131-136.
18. CORY, S. 1995. Regulation of lymphocyte survival by the bcl-2 gene family. Ann. Rev. Immunol. 13: 513-543.
19. BOIRIVANT, M., PICA, R., DE MARIA, R., TESTI, R., PALLONE, F. & STROBER, W. 1996. Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis. J. Clin. Invest. 98: 2616-2622.
20. STROBER, W. & EHRHARDT, R.O. 1993. Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell 75: 203-205.
21. DUCHMANN, R., KAISER, L. HERMANN, E., MAYET, W., EWE, K. & BUSCHEN-FELDE, K-HMZ. 1995. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102: 448-455.
22. D'HAENS, G.R., GEBOES, K., PEETERS, M., BAERT, F., PENNINCKX, F. & RUTGEERTS, P. 1998. Early lesion of recurrent Crohn's disease caused by infusion of intestinal contents in exluded ileum. Gastroenterology 114: 262-267.
23. JAMES, S.P. 1988. Remission of Crohn's disease after human immunodeficiency virus infection. Gastroenterology 95: 1667-1669.
24. FAIS, S., CAPOBIANCHI, M.R., PALLONE, F., DI MARCO, P., BOIRIVANT, M., DIANZANI, F. & TORSOLI, A. 1991. Spontaneous release of interferon-gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon-gamma inducers. Gut 32: 403-407.
25. FUSS, I.J., NEURATH, M., BOIRIVANT, M., KLEIN, J.S., DE LAMOTTE, STONG, S.A., FIOCCHI, C. & STROBER, W. 1996. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. J. Immunol. 157: 1261-1270.
26. MARINI, M., DI FELICE, G., PRONIO, A.M., MONTESANI, C. & BOIRIVANT, M. 1997. Lamina propria mononuclear cells (LPMC) from Crohn's disease (CD) patients show reduced apoptosis levels when stimulated via the CD2-activation pathway. Gastroenterology 112: A1034.
27. DBAIBO, G.S., PERRY, D.K., GAMARD, C.J., PLATT, R., POIRIER, G.G., OBEID, L.M. & HANNUN, Y.A. 1997. Cytokine response modifer A (CrmA) inhibits ceramide formation in response to tumor nececrosis factor (TNF)-α: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J. Exp. Med. 185: 481-490.
28. BOUSSIOTIS, V.A., FREEMAN, G.J., GRIFFIN, J.D., GRAY, G.S., GRIBBEN, J.G. & NADLER, L.M. 1994. CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy. J. Exp. Med. 180: 1665-1674.
29. FUSS, I.J., MARTH, T., PEARLSTEIN, G., NEURATH, M. & STROBER, W. 1997. Anti-interleukin-12 regulates apoptosis of activated Th1 T cells in murine experimental granulomatous colitis. Gastroenterology 112: A978.